Annual Cell Therapy Summit

2025 Cell Coast Conference

Transformational Breakthroughs in Cell Therapies

Moffitt Cancer Center presents

2025 Cell Coast Conference | October 17-18, 2025

Join us for an exclusive, one-of-a-kind summit featuring updates on breakthroughs in research and treatment in the cell therapies space. Global thought leaders will share their perspectives on the current and future state of the liquid and solid tumor cell therapy landscape.

Hotel Flor

Join Us October 17-18, 2025

Where will the conference be?
Hotel Flor
905 N. Florida Ave
Tampa, FL 33602

Who Should Attend the Summit?
This conference is specifically crafted for professionals in the field, including cellular therapy practitioners, hematologists, community oncologists, pharmacists, advanced practice professionals, and dedicated oncology nurses. Particular attention will be paid to the interface between referring providers and cellular therapists, including when and how to refer patients. Ample time will be available for networking.

Cell Coast Conference Learning Objectives
Discuss groundbreaking advancements in target identification, tumor microenvironment interactions, and novel immune and non-immune cell therapies shaping the future of oncology.

Evaluate the latest in cell therapy engineering, including synthetic biology, gene editing, and innovative platforms revolutionizing CAR-T, CRISPR, and CAR-NK-cell therapies.

Explain key challenges in manufacturing, in vivo CAR-T expansion, persistence, and precise delivery methods to maximize therapeutic success

2025 Cell Coast Conference Schedule

Join us in downtown Tampa, Florida for a conference designed to bring together cancer research and providers.

Friday, October 17

2:00 PM - 2:05 PM	Welcome Address
2:05 PM - 2:30 PM	Bispecific Antibody Therapy in Non-Hodgkin Lymphoma and Toxicity Management Sameh Gaballa, MD; Moffitt Cancer Center
2:30 PM – 3:00 PM	Operationalization of Tarlatamab therapy at Moffitt Cancer Center Sonam Puri, MD; Moffitt Cancer Center
3:00 PM - 3:30 PM	Bispecific Antibody Therapy for Relapsed/Refractory Multiple Myeloma Kenneth Shain, MD, PhD; Moffitt Cancer Center
3:30 PM – 4:00 PM	Panel Discussion
6:00 PM – 9:00 PM	Welcome Reception at Rooftop 220 at Armature Works

Saturday, October 18

8:00 AM - 8:30 AM	Registration, Breakfast & Exhibits
8:30 AM - 8:45 AM	Welcome Address & Opening Remarks Patrick Hwu, MD, President and CEO of Moffitt Cancer Center
8:45 AM - 9:00 AM	Keynote Speaker: Combination CAR T and anti-IFNG Strategies for the Management of Advanced Cancers Matthew Frigault, MD; Massachusetts General Hospital

SESSION 1 - Novel Targets and Approaches
MODERATOR: CIARA FREEMAN, MD

9:00 AM - 9:10 AM	Novel Cellular Therapies for Sarcoma Sandra D’Angelo, MD; Memorial Sloan Kettering Cancer Center
9:10 AM - 9:20 AM	CAR-T Cell Updates in ALL Bijal Shah, MD; Moffitt Cancer Center
9:20 AM - 9:30 AM	GPC3 CAR T Cells for the Management of Advanced Cancers David Steffin, MD; Baylor College of Medicine/Texas Children’s Hospital
9:30 AM - 9:40 AM	CAR-T for Autoimmune Diseases Sayeef Mirza, MD; Moffitt Cancer Center
9:40 AM - 9:50 AM	Biomarkers for Toxicity and Response in CAR-T for Multiple Myeloma Doris Hansen, MD; Moffitt Cancer Center
9:50 AM - 10:00 AM	In-Vivo CAR-T Laura Volta, MD; Penn Medicine
10:00 AM - 10:15 AM	Panel Discussion and Q&A
10:15 AM - 10:45 AM	Break & Exhibits

SESSION 2 - Advanced Engineering and Modalities:
MODERATOR: MICHAEL JAIN, MD

10:45 AM - 10:55 AM	Claudin 18.2 for Gastrointestinal Malignancies Dae Won Kim, MD; Moffitt Cancer Center
10:55 AM- 11:05 AM	T Cell Fitness: What’s Next after BCMA CAR Ciara Freeman, MD; Moffitt Cancer Center
11:05 AM - 11:15 AM	Armored CAR-T Strategies for Advanced Cancers Marco Davila, MD; Roswell Park
11:15 AM - 11:25 AM	Allogeneic “off the shelf” IO approaches for MDS/AML David Sallman, MD; Moffitt Cancer Center
11:25 AM - 11:35 AM	CAR-NK Strategies for the Management of Advanced Cancers May Daher, MD; MD Anderson Cancer Center
11:35 AM - 11:45 PM	Bladder Til Trial Michael Poch, MD; Moffitt Cancer Center
11:45 PM - 12:00 PM	Panel Discussion and Q&A
12:00 - 1:00 PM	Lunch Break & Exhibits

SESSION 3 - Optimizing Delivery and Efficacy:
MODERATOR: JOHN MULLINAX, MD

1:00 PM - 1:10 PM:	Future of TIL Therapy David Olson, MD; University of Chicago
1:10 PM - 1:20 PM:	Novel TIL Therapies in Lung Cancer Adam Schoenfeld, MD; Memorial Sloan Kettering Cancer Center
1:20 PM - 1:30 PM:	Combination CAR-T Strategies: CD19/CD22 CART and Orca-T allo-SCT in BALL Lori Muffly, MD; Stanford Medicine
1:30 PM - 1:40 PM:	CAR-T for Glioblastoma Brian Stocksdale, MD: Stanford Medicine
1:40 PM - 1:50 PM:	GCC19 CAR T Trial Benjamin Schlechter, MD; Dana Farber Cancer Institute
1:50 PM - 2:00 PM:	Panel Discussion and Q&A
2:00 PM - 2:30 PM	Break & Exhibits

SESSION 4 - Debate and an APRNs Point of View:
MODERATOR: FRED LOCKE, MD

2:30 PM - 2:50 PM:	Practical /Logistics of Clinical Care for Cell Therapy Patients Marian Dam, APRN; Moffitt Cancer Center
2:50 - 3:10 PM	Debate: CAR-T vs BITEs for Hematologic Malignancies Michael Jain, MD; Moffitt Cancer Center vs. Omar Castaneda-Puglianini, MD; Moffitt Cancer Center
3:10 PM - 3:15 PM	Closing Remarks

2025 Cell Coast Conference

Moffitt Cancer Center presents

2025 Cell Coast Conference | October 17-18, 2025

Join Us October 17-18, 2025

SESSION 1 - Novel Targets and ApproachesMODERATOR: CIARA FREEMAN, MD

SESSION 2 - Advanced Engineering and Modalities:MODERATOR: MICHAEL JAIN, MD

SESSION 3 - Optimizing Delivery and Efficacy:MODERATOR: JOHN MULLINAX, MD

SESSION 4 - Debate and an APRNs Point of View:MODERATOR: FRED LOCKE, MD

Immunotherapy Headlines

Cambiar el idioma

SESSION 1 - Novel Targets and Approaches
MODERATOR: CIARA FREEMAN, MD

SESSION 2 - Advanced Engineering and Modalities:
MODERATOR: MICHAEL JAIN, MD

SESSION 3 - Optimizing Delivery and Efficacy:
MODERATOR: JOHN MULLINAX, MD

SESSION 4 - Debate and an APRNs Point of View:
MODERATOR: FRED LOCKE, MD